eGenesis Announces IND Clearance for EGEN-2784 in Pig Kidney Transplant and Landmark Patient Updates in Ongoing Expanded Access Study
On Sept. 8, 2025, eGenesis announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational…